FindTrial
Sign In

A trial studying the outcomes, both in the mother and baby, at delivery conducted at different weeks of pregnancy, in women with Intrahepatic Cholestasis of Pregnancy

Gestational age at delivery and maternal and perinatal outcomes in women with intrahepatic cholestasis of pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/05/019410
Enrollment
100
Registered
2019-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O266- Liver and biliary tract disordersin pregnancy, childbirth and the puerperium

Interventions

None listed

Sponsors

Maulana Azad Medical College
Lead Sponsor
Dr Latika Sahu
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Women with singleton pregnancy after 28weeks of gestation with confirmed Intrahepatic Cholestatsis of Pregnancy Intrahepatic Cholestatis of Pregnancy defined as Pruritis in pregnancy with other causes excluded and increased ALT ( >30IU/L) and serum Bile acid > upper limit of normal

Exclusion criteria

Exclusion criteria: Pregnant women Laboratory confirmed Hepatitis A, Hepatitis B, Hepatitis C, Cytomegalovirus, EB virus Preeclampsia Acute Fatty Liver of pregnancy Primary hepatic disorders known case of Alpha 1 antitrypsin deficiency Currently on drugs causing deranged liver enzymes Lethal fetal anomaly

Design outcomes

Primary

MeasureTime frame
Maternal Gestational age at delivery Mode of onset of labour Rate of caesarean sections Indication of caesarean section Timepoint: 2 weeks—

Secondary

MeasureTime frame
other maternal and perinatal morbidiy and mortalityTimepoint: 2 weeks—

Countries

India

Contacts

Public ContactDr Kalyani Nair

Maulana Azad Medical College

latikasahu@gmail.com996860400

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026